KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Tax Provisions (2020 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Tax Provisions for 6 consecutive years, with -$175.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions fell 57513.49% year-over-year to -$175.1 million, compared with a TTM value of -$173.0 million through Dec 2025, down 10303.12%, and an annual FY2025 reading of -$173.0 million, down 10303.12% over the prior year.
  • Tax Provisions was -$175.1 million for Q4 2025 at Aurinia Pharmaceuticals, down from $500000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $1.0 million in Q1 2025 and bottomed at -$175.1 million in Q4 2025.
  • Average Tax Provisions over 5 years is -$8.4 million, with a median of $447500.0 recorded in 2023.
  • The sharpest move saw Tax Provisions skyrocketed 11825.0% in 2022, then plummeted 57513.49% in 2025.
  • Year by year, Tax Provisions stood at $726000.0 in 2021, then rose by 13.91% to $827000.0 in 2022, then crashed by 44.5% to $459000.0 in 2023, then crashed by 166.23% to -$304000.0 in 2024, then tumbled by 57513.49% to -$175.1 million in 2025.
  • Business Quant data shows Tax Provisions for AUPH at -$175.1 million in Q4 2025, $500000.0 in Q3 2025, and $600000.0 in Q2 2025.